InfantRisk HCP vs ASCCP Management Guidelines

Pregnant and breastfeeding patients deserve safe, effective care. Too often, treatment decisions are clouded by uncertainty. InfantRisk HCP gives healthcare professionals fast, evidence-based guidance on medication safety in pregnancy and lactation—so you can make confident choices in seconds. Developed by leading researchers and clinicians, the app provides: • Quick drug safety ratings (1 = safest, 5 = most hazardous) for pregnancy and breastfeeding • Access to over 70,000 medications with concise, evidence-based summaries • Easy comparison of safety ratings by indication or drug class • A clean, intuitive interface with monthly data updates Are you a parent? Try our companion app, MommyMeds, written with patients in mind. Subscription: $14.99 USD per year Terms of Use: https://www.infantrisk.com/infantrisk-hcp-terms-use Disclaimer: The information in InfantRisk HCP is designed to support—not replace—clinical judgment and individualized patient care.

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.